Reaction
Acute Interstitial Pneumonitis reporting signals
As of the last recalculation, Acute Interstitial Pneumonitis appears in 517 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is DAPTOMYCIN (PRR 76.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Daptomycin | 17 | 76.7 | 76.8 |
| Granisetron Hydrochloride | 9 | 35.3 | 35.3 |
| Granisetron | 9 | 35.1 | 35.2 |
| Pemetrexed | 18 | 35.0 | 35.0 |
| Bleomycin Sulfate | 7 | 27.6 | 27.7 |
| Pertuzumab | 18 | 27.6 | 27.6 |
| Pemetrexed Disodium | 20 | 21.9 | 22.0 |
| Trastuzumab | 32 | 19.9 | 20.0 |
| Docetaxel Anhydrous | 29 | 18.3 | 18.3 |
| Docetaxel | 29 | 18.3 | 18.3 |
| Paclitaxel (Aibumin-Bound) | 31 | 16.1 | 16.1 |
| Paclitaxel | 36 | 15.7 | 15.7 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 6 | 14.6 | 14.6 |
| Abemaciclib | 7 | 14.3 | 14.3 |
| Erlotinib | 3 | 12.5 | 12.5 |
| Fam-Trastuzumab Deruxtecan-Nxki | 3 | 12.0 | 12.0 |